HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Nagata Selected Research

TX 2100

6/2006The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
2/2006Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Nagata Research Topics

Disease

35Neoplasms (Cancer)
04/2021 - 04/2002
9Hepatocellular Carcinoma (Hepatoma)
05/2019 - 01/2003
7Infections
04/2022 - 01/2008
7Fibrosis (Cirrhosis)
01/2021 - 11/2003
5Hepatitis C
08/2021 - 01/2008
5Neoplasm Metastasis (Metastasis)
04/2021 - 07/2006
5Liver Cirrhosis (Hepatic Cirrhosis)
08/2019 - 03/2006
5Carcinoma (Carcinomatosis)
07/2006 - 04/2002
4Uveitis
11/2017 - 06/2012
4Sarcoidosis (Schaumann Disease)
11/2017 - 06/2012
4Hyperthermia
02/2007 - 01/2003
3Thrombosis (Thrombus)
01/2013 - 03/2003
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2009 - 11/2004
3Malignant Mesothelioma
08/2008 - 12/2006
3Hypoxia (Hypoxemia)
06/2006 - 10/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 04/2021
2Splenomegaly
01/2021 - 01/2017
2Primary Myelofibrosis (Myelosclerosis)
01/2021 - 01/2019
2Leukemia
01/2020 - 01/2019
2Macular Edema
01/2020 - 06/2012
2Small Cell Carcinoma
10/2019 - 07/2019
2Acute Liver Failure (Fulminant Hepatic Failure)
10/2019 - 12/2005
2Virus Diseases (Viral Diseases)
11/2017 - 01/2013
2Rheumatoid Arthritis
09/2015 - 01/2011
2Chronic Hepatitis (Chronic Active Hepatitis)
01/2013 - 09/2008
2Liver Diseases (Liver Disease)
04/2010 - 07/2006
2Viremia
08/2009 - 01/2008
2Squamous Cell Carcinoma of Head and Neck
01/2006 - 05/2004
1Pneumonia (Pneumonitis)
11/2021
1Frailty
08/2021
1Anemia
01/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020
1Diabetes Mellitus
11/2019
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2019
1Cushing Syndrome
10/2019
1Essential Thrombocythemia
01/2019
1Central Serous Chorioretinopathy
12/2018
1Disease Progression
12/2018
1Pruritus (Itching)
12/2017
1Headache (Headaches)
12/2017
1Sleep Initiation and Maintenance Disorders (Insomnia)
12/2017
1Constipation
12/2017

Drug/Important Bio-Agent (IBA)

15Bromodeoxyuridine (BrdU)IBA
01/2008 - 01/2003
9Cytochalasin BIBA
03/2006 - 01/2003
8SuspensionsIBA
03/2006 - 01/2003
5mercaptoundecahydrododecaborate (borocaptate sodium)IBA
11/2009 - 03/2004
4BoronIBA
10/2007 - 05/2004
4Amino AcidsFDA Link
05/2007 - 11/2003
4Choline (Choline Chloride)IBA
05/2007 - 11/2003
4Tirapazamine (SR 4233)IBA
02/2007 - 01/2003
4Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2006 - 06/2005
4SodiumIBA
12/2005 - 05/2004
3Antiviral Agents (Antivirals)IBA
08/2021 - 01/2019
3CytokinesIBA
01/2021 - 06/2012
3Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2007
3DNA (Deoxyribonucleic Acid)IBA
11/2017 - 04/2002
3AntigensIBA
09/2013 - 01/2008
3CDAA (Randox)IBA
05/2007 - 08/2005
3N-acetylcochinol-O-phosphateIBA
01/2007 - 11/2004
3Cytotoxins (Cytolysins)IBA
01/2007 - 08/2005
3Boron CompoundsIBA
12/2006 - 05/2004
3EmulsionsIBA
11/2004 - 03/2004
3Ethiodized Oil (Ethiodol)FDA Link
11/2004 - 03/2004
2CollagenIBA
01/2021 - 08/2019
2CalreticulinIBA
01/2020 - 01/2019
2InterferonsIBA
05/2019 - 06/2012
2Biomarkers (Surrogate Marker)IBA
11/2017 - 04/2010
2Retinaldehyde (Retinal)IBA
11/2017 - 09/2015
2Tumor Necrosis Factor InhibitorsIBA
09/2015 - 01/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2015 - 01/2011
2Warfarin (Coumadin)FDA LinkGeneric
01/2013 - 04/2010
2Pharmaceutical PreparationsIBA
01/2013 - 03/2006
2Prednisolone (Predate)FDA LinkGeneric
01/2013 - 04/2010
2RNA (Ribonucleic Acid)IBA
08/2009 - 01/2006
2WortmanninIBA
12/2007 - 05/2003
2TX 2100IBA
06/2006 - 02/2006
23-amino-2-quinoxalinecarbonitrileIBA
02/2006 - 08/2005
1glecaprevir and pibrentasvirIBA
04/2022
1durvalumabIBA
11/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2021
1Immune Checkpoint InhibitorsIBA
04/2021
1pembrolizumabIBA
04/2021
1Fibronectins (Fibronectin)IBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1Biological ProductsIBA
01/2020
1afliberceptIBA
01/2020
1Lactic Acid (Lactate)FDA LinkGeneric
11/2019
1Adrenocorticotropic Hormone (ACTH)FDA Link
10/2019
1Carbon Tetrachloride (Tetrachloromethane)IBA
08/2019
1Messenger RNA (mRNA)IBA
08/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2018
1SofosbuvirIBA
12/2017
1ledipasvirIBA
12/2017

Therapy/Procedure

18Boron Neutron Capture Therapy
08/2008 - 03/2004
14Therapeutics
11/2021 - 01/2003
12Radiotherapy
01/2020 - 04/2002
4Drug Therapy (Chemotherapy)
04/2021 - 07/2006
3Chemoradiotherapy
11/2021 - 08/2003
2Injections
01/2020 - 06/2005
2Intravenous Injections
03/2006 - 06/2005